Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 4Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 127Breast Neoplasms 110Neoplasms 95Neoplasm Metastasis 78Melanoma 71Leukemia, Myeloid, Acute 68Colorectal Neoplasms 67Prostatic Neoplasms 59Ovarian Neoplasms 51Multiple Myeloma 51Lung Neoplasms 50Squamous Cell Carcinoma of Head and Neck 47Triple Negative Breast Neoplasms 42Recurrence 42Carcinoma, Renal Cell 40Carcinoma, Hepatocellular 39Myelodysplastic Syndromes 35Pancreatic Neoplasms 34Glioblastoma 34Brain Neoplasms 31Stomach Neoplasms 30Lymphoma 30Lymphoma, Non-Hodgkin 28Lymphoma, Large B-Cell, Diffuse 28Leukemia 28Head and Neck Neoplasms 28Endometrial Neoplasms 28Uterine Cervical Neoplasms 26Cholangiocarcinoma 26Urinary Bladder Neoplasms 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pathologic Processes × 1 year × Clear all
NCT03694015 2026-03-11

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

British Columbia Cancer Agency

Phase NA Terminated
160 enrolled

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡